Search results
Results from the WOW.Com Content Network
Siddhartha Mukherjee (Bengali: সিদ্ধার্থ মুখার্জী; born 21 July 1970) [1] is an Indian-American physician, biologist, and author. He is best known for his 2010 book, The Emperor of All Maladies: A Biography of Cancer, that won notable literary prizes including the 2011 Pulitzer Prize for General Nonfiction, [2] and Guardian First Book Award, [3] among others.
The book weaves together Mukherjee's experiences as a hematology/oncology fellow at Massachusetts General Hospital as well as the history of cancer treatment and research. [2] [3] Mukherjee gives the history of cancer from its first identification 4,600 years ago by the Egyptian physician Imhotep. The Greeks had no understanding of cells, but ...
In India, he has launched a Phase 2B study into the use of CAR-T cells—a specialized type of lab-altered T-cells—to battle cancer in a small sample group of patients.
The Gene: An Intimate History is a book written by Siddhartha Mukherjee, an Indian-born American physician and oncologist. It was published on 17 May 2016 by Scribner . [ 1 ] The book chronicles the history of the gene and genetic research, all the way from Aristotle to Crick , Watson and Franklin and then the 21st century scientists who mapped ...
A candlestick chart (also called Japanese candlestick chart or K-line) is a style of financial chart used to describe price movements of a security, derivative, or currency. While similar in appearance to a bar chart, each candlestick represents four important pieces of information for that day: open and close in the thick body, and high and ...
A candlestick chart (also called Japanese candlestick chart or K-line [7]) is a style of financial chart used to describe price movements of a security, derivative, or currency. Stock price prediction based on K-line patterns is the essence of candlestick technical analysis.
In 2014, Dr Lal PathLabs acquired the APL Clinical Institute of Clinical Laboratory & Research Private Limited. [6] Dr Lal PathLabs launched its IPO in 2015. [7] The company got listed on BSE and NSE on 23 December 2015. [8] In 2021, Dr Lal PathLabs acquired Suburban Diagnostics for an enterprise value of ₹ 925 crore in an all-cash deal. [9]
Divi's Laboratories Limited is an Indian multinational pharmaceutical company and producer of active pharmaceutical ingredients (APIs) and intermediates, headquartered in Hyderabad. [ 5 ] [ 6 ] [ 2 ] [ 7 ] The company manufactures and custom synthesizes generic APIs, intermediates.